A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial

Chiba, Yohei; Sudo, Kazuki; Kojima, Yuki; Okuma, Hitomi; Kohsaka, Shinji; Machida, Ryunosuke; Ichimura, Masahiko; Anjo, Kenta; Kurishita, Kazumi; Okita, Natsuko; Nakamura, Kenichi; Kinoshita, Ichiro; Takahashi, Masanobu; Matsubara, Junichi; Kusaba, Hitoshi; Yonemori, Kan; Takahashi, Masamichi

doi:10.1186/s12885-022-09949-8

BMC Cancer

Article metrics
Last updated: Fri, 19 Apr 2024 22:00:01 Z

A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial

Access & Citations

2154

Article Accesses
2

Web of Science
4

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com